Literature DB >> 6155727

13,14-Dihydro-15-keto-prostaglandin F2 alpha in patients with urogenital tumors.

U Dunzendorfer, H P Zahradnik, K Gerster.   

Abstract

13,14-Dihydro-15-keto-prostaglandin F2 alpha (13,14-DHK-PGF2 alpha) represents a stable product of degradation after pulmonary flow and it is shown to be reliably measured by radioimmunoassay. In patients with urogenital tumors, serum levels of 13,14-DHK-PGF2 alpha are distinctly elevated when compared to a control group. The rate of synthesis of this compound in urogenital tumors, however, appears to be different.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155727     DOI: 10.1159/000280319

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  1 in total

1.  The response of neoplastic intestinal vessels to prostaglandin F2 alpha: angiographic observations with emphasis on therapeutic applications.

Authors:  S Kusano; K Murata; S Tominaga; T Matsubayashi; S Matama; T Takahashi
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.